Physician

Internal Medicine

Mardge Cohen is an expert in the field of Internal Medicine. Mardge Cohen is a published doctor and has 106 publications published. The lastest was: 'Utilization of Alcohol Treatment Among HIV-Positive Women with Hazardous Drinking.'

Publications

---

• CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception.
• The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
• Gender-related risk factors improve mortality predictive ability of VACS Index among HIV-infected women.
• Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a ...
• The association of perceived stress and verbal memory is greater in HIV-infected versus HIV-uninfected women.
• Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV ...
• Sexual Behavior and Risk Practices of HIV Positive and HIV Negative Rwandan Women.
• Genetic predictor of working memory and prefrontal function in women with HIV.
• Association of Urine α1-Microglobulin with Kidney Function Decline and Mortality in HIV-Infected Women.
• Association of Markers of Hemostasis With Death in HIV-Infected Women.
• Investigating the effects of metabolic dysregulation on hair follicles: a comparison of HIV-infected women with and without central lipohypertrophy.
• Serum Albumin and Kidney Function Decline in HIV-Infected Women.
• Longitudinal Trends in Sexual Behaviors with Advancing Age and Menopause Among Women With and Without HIV-1 Infection.
• Gender Roles and Mental Health in Women With and at Risk for HIV.
• Long-term cumulative detection of human papillomavirus among HIV seropositive women.
• Gender Role Behaviors of High Affiliation and Low Self-Silencing Predict Better Adherence to Antiretroviral Therapy in Women with HIV.
• Do HIV-positive women receive depression treatment that meets best practice guidelines?
• Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in the Women's Interagency HIV Study.
• Crack cocaine use impairs anterior cingulate and prefrontal cortex function in women with HIV infection.
• Psychosocial Correlates of Gender-Based Violence Among HIV-infected and HIV-Uninfected Women in Three US Cities.
• Sexual Minority Status and Violence Among HIV Infected and At-Risk Women.
• Smoking Cessation and Recidivism in the Women's Interagency Human Immunodeficiency Virus Study.
• Resilience among women with HIV: Impact of silencing the self and socioeconomic factors.
• Macrophage Inflammatory Markers Are Associated With Subclinical Carotid Artery Disease in Women With Human Immunodeficiency Virus or Hepatitis C Virus Infection.
• Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women.
• Abuse and Resilience in Relation to HAART Medication Adherence and HIV Viral Load Among Women with HIV in the United States.
• RYR3 gene variants in subclinical atherosclerosis among HIV-infected women in the Women's Interagency HIV Study (WIHS).
• Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study.
• INCREASE IN SINGLE-TABLET REGIMEN USE AND ASSOCIATED IMPROVEMENTS IN ADHERENCE-RELATED OUTCOMES IN HIV-INFECTED WOMEN.
• Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women.
• Single-Nucleotide Polymorphisms in TrkB and Risk for Depression: Findings From the Women's Interagency HIV Study.
• Cause-specific mortality among HIV-infected individuals, by CD4+cell count at HAART initiation, compared with HIV-uninfected individuals.
• Serum biomarkers of immune activation and subsequent risk of non-Hodgkin B cell lymphoma among HIV-infected women.
• Critical Consciousness, Racial and Gender Discrimination, and HIV Disease Markers in African American Women with HIV.
• Comparison of Antibodies That Mediate HIV Type 1 gp120 Antibody-Dependent Cell-Mediated Cytotoxicity in Asymptomatic HIV Type 1-Positive Men and Women.
• Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.
• Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
• Does HIV infection promote early kidney injury in women?
• HIV serostatus differs by catechol-O-methyltransferase Val158Met genotype.
• The association of self-perception of body fat changes and quality of life in the Women's Interagency HIV Study.
• Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women.
• Host APOL1 genotype is independently associated with proteinuria in HIV infection.
• Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus.
• Vitamin D and Insulin Resistance in Non-Diabetic Women's Interagency HIV Study Participants.
• HIV and Recent Illicit Drug Use Interact to Affect Verbal Memory in Women.
• Gonadotropin and Sex Steroid Levels in HIV-Infected Premenopausal Women and Their Association With Subclinical Atherosclerosis in HIV-Infected and -Uninfected Women in...
• Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART.
• Differences in the Nonuse of any Contraception and Use of Specific Contraceptive Methods in HIV Positive and HIV Negative Rwandan Women.
• Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed s...
• Antiretroviral-Treated HIV-Infected Women Have Similar Long-Term Kidney Function Trajectories as HIV-Uninfected Women.
• The association between diet and physical activity on insulin resistance in the Women's Interagency HIV Study.
• 'I think my future will be better than my past': Examining support group influence on the mental health of HIV-infected Rwandan women.
• The impact of HIV status, HIV disease progression, and post-traumatic stress symptoms on the health-related quality of life of Rwandan women genocide survivors.
• Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine.
• Negative predictive value of pap testing: implications for screening intervals for women with human immunodeficiency virus.
• Bacterial Vaginosis and Vitamin D Deficiency Among Nonpregnant HIV-Infected and Uninfected Women in the United States.
• Human Leukocyte Antigen (HLA) Genotype and Risk of HIV Disease Progression Before and After Initiation of Antiretroviral Therapy.
• Improvement in Posttraumatic Stress Disorder in Postconflict Rwandan Women.
• The Relation of HLA Genotype to Hepatitis C Viral Load and Markers of Liver Fibrosis in HIV-Infected and HIV-Uninfected Women.
• Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.
• Factors associated with declining a rapid human immunodeficiency virus test in labor and delivery.
• The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.
• Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection.
• Multi-dimensional risk factor patterns associated with non-use of highly active antiretroviral therapy among human immunodeficiency virus-infected women.
• HIV infection and women's sexual functioning.
• Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005.
• The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study.
• Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
• HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study.
• Short-term bone loss in HIV-infected premenopausal women.
• Smoking cessation among women with and at risk for HIV: are they quitting?
• Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.
• Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection.
• Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.
• Prevalence and predictors of posttraumatic stress disorder and depression in HIV-infected and at-risk Rwandan women.
• Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.
• Factors associated with prenatal care use among peripartum women in the Mother-Infant Rapid Intervention at Delivery study.
• Trends in mortality and causes of death among women with HIV in the United States: a 10-year study.
• Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study.
• Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.
• Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006.
• Protease inhibitor levels in hair strongly predict virologic response to treatment.
• Women identified with HIV at labor and delivery: testing, disclosing and linking to care challenges.
• Correlates of prenatal HIV testing in women with undocumented status at delivery.
• Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
• Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
• Awareness of hepatitis C infection among women with and at risk for HIV.
• Ten-year predicted coronary heart disease risk in HIV-infected men and women.
• Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience.
• Ready or not--intrapartum prevention of perinatal HIV transmission in Illinois.
• Primary human immunodeficiency virus infection during pregnancy detected by repeat testing.
• AZT Availability in Illinois birthing hospitals: is the perinatal HIV prevention safety net in place?
• Obesity and immune cell counts in women.
• Antiretroviral therapies associated with lipoatrophy in HIV-infected women.
• Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships.
• Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.
• Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV/AIDS.
• Relationship of U1 cell HIV-stimulatory activity to bacterial vaginosis and HIV genital tract virus load.
• Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.
• Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosi...
• Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.
• Systemic Immune Activation and HIV Shedding in the Female Genital Tract.
• Mechanisms For The Negative Effects Of Internalized Hiv-Related Stigma On Art Adherence In Women: The Mediating Roles Of Social Isolation And Depression.
• Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
• Utilization of Alcohol Treatment Among HIV-Positive Women with Hazardous Drinking.

Schools

---

• Rush University

Doctors Specialties

---

• Internal Medicine

Accepted Insurances

---

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Terrell Y. Johnson, MD This Doctor is OpenDoctor Recommended.
	Dr. Phuoc V. Le, MD
	Dr. Amy K. Barczak, MD This Doctor is OpenDoctor Recommended.
	Irving H. Goldberg This Doctor is OpenDoctor Recommended.
	Dr. Gregory Hundemer, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph B. Crocker, MD This Doctor is OpenDoctor Recommended.
	Dr. Bonnie A. Southworth, MD This Doctor is OpenDoctor Recommended.
	Dr. David I. Rosenthal, MD
	Dr. Caitlin M. Fawcett, MD This Doctor is OpenDoctor Recommended.
	Dr. Carol J. Zuckerman, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah W. Flores, MD
	Dr. Tejal K. Gandhi, MD This Doctor is OpenDoctor Recommended.
	Dr. Edward W. Campion, MD This Doctor is OpenDoctor Recommended.
	Dr. Tammy T. Hshieh, MD This Doctor is OpenDoctor Recommended.
	Dr. Joan I. Kross, MD This Doctor is OpenDoctor Recommended.
	Kathleen Kennedy McCarey, NP This Doctor is OpenDoctor Recommended.
	Dr. Nicholas Joza, MD This Doctor is OpenDoctor Recommended.
	Dr. Monica Campo, MD
	Dr. Corey E. Tabit, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog